Skip to main content
Premium Trial:

Request an Annual Quote

Sound Waves Soothe the Savage Cancer


At the recent International Conference on Microtechnologies in Medicine and Biology, researchers from the Institute for Acoustics in Spain presented a device they created that filters cancer cells from samples of human blood using sound waves, says New Scientist's Lucas Laursen. The new technology could help clinicians identify whether a tumor has metastasized. The blood flows through a small, vibrating plastic chamber, and the vibrations create a wave that separates cells according to their size, Laursen says. Because tumor cells are larger than blood cells, they collect in a different region of the device, and clinicians can then evaluate tumor progression based on how many cancer cells there are in the blood sample. "The prototype can reliably differentiate cancer cells 70 percent of the time, and a modified version that exposes the blood to the acoustic waves for a longer amount of time should be able to differentiate a cancer cell from a normal cell 95 percent of the time," Laursen adds. Typically, finding just two or three tumor cells in a seven milliliter sample of blood is enough to make a determination that a cancer is metastasizing, the researchers say.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.